New to Animal Pharm?
Start a free trial today to access this content and much more.
If your company has access but you haven't yet registered, click below:
Covetrus CEO opens up on 'self-inflicted missteps' of company's early days
The new chief executive of Covetrus has spoken publicly about the firm's recent struggles and claims it will now aim to be a more open company.
ViroVet hopes ASF antiviral blocker could be ready for emergency use next year
Belgian start-up ViroVet claims its work on a preventative for African swine fever (ASF) could be used on an emergency basis as early as next year.
Trans-Asian pet vaccine joint venture sees Kyoritsu Seiyaku partner with Jinyu
Japan's leading animal health company Kyoritsu Seiyaku has set up a joint venture with Jinyubaoling Bio-Pharmaceutical – a subsidiary of China's biggest animal vaccines maker Jinyu Bio-technology.
AGL developing new animal monitoring technology innovations and partnerships
US firm AGL has been working in the digital technology space since 2014, long before many recent newcomers arrived on the scene. Animal Pharm editor Joseph Harvey spoke to the company's co-founder, president and chief executive Marcel Sarzen to find out AGL's present game plan.
Animal Biosciences targets innovation for aging companion animals
US company Animal Biosciences hopes to become the latest start-up to take innovation from the human medicine sector and take it into the animal health market.
Strong Zoetis Q3 backed by pet portfolio performance, boost from Abaxis
Zoetis has secured healthy sales growth in the third quarter of 2019, as its companion animal unit once again showed an exceptional performance.
Recent Tweets from Animal PharmCommercial
Chinese companies begin to feel the burden of ASF on revenues
Chinese animal health firms were not unscathed by African swine fever (ASF) in 2018 but the disease arrived too late in the calendar year for it to seriously trouble companies' full-year results. However, pressure started to emerge in the first-half of 2019, Animal Pharm correspondent Louis Harkell reports.
Latest From
Pirbright bags $5.5m from Gates Foundation to establish livestock antibody hub
The Pirbright Institute has received $5.5 million in funding from the Bill & Melinda Gates Foundation to develop a livestock antibody hub.
Merck gets further Bravecto Plus boost with US approval for cats
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Phibro will make decision on ASF vaccine in next 12 months
Phibro Animal Health will decide whether to carry on developing a vaccine against African swine fever (ASF) in the next 12 months.
Avivagen bags another major order in Asia, seeks China approval
Canadian firm Avivagen has secured another order of its feed premix OxC-beta Livestock from UNAHCO – its distribution partner in the Philippines.
Alivira maintains strong fiscal 2020 into second quarter
India's Alivira Animal Health has posted 13% sales growth in the second quarter of fiscal 2020.
Boehringer horse asthma product secures EU positive opinion
European authorities have given the go-ahead for Boehringer Ingelheim Animal Health's Aservo EquiHaler to be approved.
Top Interviews & Analysis
vHive head Alasdair Cook casts eye over digital tech in animal health
Next week, start-ups, investors and longstanding firms in the animal health sector will gather at the Digital Veterinary Summit in London. Animal Pharm analyst Sian Lazell spoke to Dr Alasdair Cook – head of the vHive innovation hub at the University of Surrey – to gain an overview of the digital technology space within the industry.
Products
First vet vaccine using Algenex technology submitted for European approval
An unnamed industry partner of Spanish firm Algenex has submitted a veterinary vaccine for European centralized approval.
Latest From
Pirbright bags $5.5m from Gates Foundation to establish livestock antibody hub
The Pirbright Institute has received $5.5 million in funding from the Bill & Melinda Gates Foundation to develop a livestock antibody hub.
Merck gets further Bravecto Plus boost with US approval for cats
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Phibro will make decision on ASF vaccine in next 12 months
Phibro Animal Health will decide whether to carry on developing a vaccine against African swine fever (ASF) in the next 12 months.
Avivagen bags another major order in Asia, seeks China approval
Canadian firm Avivagen has secured another order of its feed premix OxC-beta Livestock from UNAHCO – its distribution partner in the Philippines.
Alivira maintains strong fiscal 2020 into second quarter
India's Alivira Animal Health has posted 13% sales growth in the second quarter of fiscal 2020.
Boehringer horse asthma product secures EU positive opinion
European authorities have given the go-ahead for Boehringer Ingelheim Animal Health's Aservo EquiHaler to be approved.
Data Pharm
Vetoquinol revenues climb 11% in Q3, boosted by impact of acquisitions
Vetoquinol has posted its strongest quarterly sales growth in 2019 so far.
ASF hurts Boehringer sales performance in first half
Boehringer Ingelheim Animal Health said its first-half revenues were impacted by the ongoing outbreak of African swine fever (ASF) in Asia.
Sectors
Cainthus: 'Farmers want to manage a cow as if it's their only one'
At the recent Digital Veterinary Summit in London, David Hunt of Irish firm Cainthus gave an overview of how artificial intelligence and computer vision can improve the productivity of an ever-changing livestock sector. Animal Pharm editor Joseph Harvey was in attendance.
Latest From
Pirbright bags $5.5m from Gates Foundation to establish livestock antibody hub
The Pirbright Institute has received $5.5 million in funding from the Bill & Melinda Gates Foundation to develop a livestock antibody hub.
Merck gets further Bravecto Plus boost with US approval for cats
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Phibro will make decision on ASF vaccine in next 12 months
Phibro Animal Health will decide whether to carry on developing a vaccine against African swine fever (ASF) in the next 12 months.
Avivagen bags another major order in Asia, seeks China approval
Canadian firm Avivagen has secured another order of its feed premix OxC-beta Livestock from UNAHCO – its distribution partner in the Philippines.
Alivira maintains strong fiscal 2020 into second quarter
India's Alivira Animal Health has posted 13% sales growth in the second quarter of fiscal 2020.
Boehringer horse asthma product secures EU positive opinion
European authorities have given the go-ahead for Boehringer Ingelheim Animal Health's Aservo EquiHaler to be approved.
Latest From
Pirbright bags $5.5m from Gates Foundation to establish livestock antibody hub
The Pirbright Institute has received $5.5 million in funding from the Bill & Melinda Gates Foundation to develop a livestock antibody hub.
Merck gets further Bravecto Plus boost with US approval for cats
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Phibro will make decision on ASF vaccine in next 12 months
Phibro Animal Health will decide whether to carry on developing a vaccine against African swine fever (ASF) in the next 12 months.
Avivagen bags another major order in Asia, seeks China approval
Canadian firm Avivagen has secured another order of its feed premix OxC-beta Livestock from UNAHCO – its distribution partner in the Philippines.
Alivira maintains strong fiscal 2020 into second quarter
India's Alivira Animal Health has posted 13% sales growth in the second quarter of fiscal 2020.
Boehringer horse asthma product secures EU positive opinion
European authorities have given the go-ahead for Boehringer Ingelheim Animal Health's Aservo EquiHaler to be approved.
Policy & Regulation
Animal Medicines Australia criticizes government plan to establish APVMA board
Industry body Animal Medicines Australia (AMA) has voiced disapproval of the decision by the country's government to introduce a board to the Australian Pesticides and Veterinary Medicines Authority (APVMA).
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.